Literature DB >> 11498583

Human hypertension caused by mutations in WNK kinases.

F H Wilson1, S Disse-Nicodème, K A Choate, K Ishikawa, C Nelson-Williams, I Desitter, M Gunel, D V Milford, G W Lipkin, J M Achard, M P Feely, B Dussol, Y Berland, R J Unwin, H Mayan, D B Simon, Z Farfel, X Jeunemaitre, R P Lifton.   

Abstract

Hypertension is a major public health problem of largely unknown cause. Here, we identify two genes causing pseudohypoaldosteronism type II, a Mendelian trait featuring hypertension, increased renal salt reabsorption, and impaired K+ and H+ excretion. Both genes encode members of the WNK family of serine-threonine kinases. Disease-causing mutations in WNK1 are large intronic deletions that increase WNK1 expression. The mutations in WNK4 are missense, which cluster in a short, highly conserved segment of the encoded protein. Both proteins localize to the distal nephron, a kidney segment involved in salt, K+, and pH homeostasis. WNK1 is cytoplasmic, whereas WNK4 localizes to tight junctions. The WNK kinases and their associated signaling pathway(s) may offer new targets for the development of antihypertensive drugs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11498583     DOI: 10.1126/science.1062844

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  489 in total

1.  Intron-size constraint as a mutational mechanism in Rothmund-Thomson syndrome.

Authors:  Lisa L Wang; Kim Worley; Anu Gannavarapu; Murali M Chintagumpala; Moise L Levy; Sharon E Plon
Journal:  Am J Hum Genet       Date:  2002-05-09       Impact factor: 11.025

Review 2.  Negative regulators of sodium transport in the kidney: key factors in understanding salt-sensitive hypertension?

Authors:  Bernard C Rossier
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

3.  WNK kinases regulate thiazide-sensitive Na-Cl cotransport.

Authors:  Chao-Ling Yang; Jordan Angell; Rose Mitchell; David H Ellison
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

4.  Paracellular ion channel at the tight junction.

Authors:  Vivian W Tang; Daniel A Goodenough
Journal:  Biophys J       Date:  2003-03       Impact factor: 4.033

5.  Sgk: an old enzyme revisited.

Authors:  Nicolette Farman; Sheerazed Boulkroun; Nathalie Courtois-Coutry
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

6.  Decreased ENaC expression compensates the increased NCC activity following inactivation of the kidney-specific isoform of WNK1 and prevents hypertension.

Authors:  Juliette Hadchouel; Christelle Soukaseum; Cara Büsst; Xiao-ou Zhou; Véronique Baudrie; Tany Zürrer; Michelle Cambillau; Jean-Luc Elghozi; Richard P Lifton; Johannes Loffing; Xavier Jeunemaitre
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

7.  Actions of the protein kinase WNK1 on endothelial cells are differentially mediated by its substrate kinases OSR1 and SPAK.

Authors:  Hashem A Dbouk; Lauren M Weil; G K Sachith Perera; Michael T Dellinger; Gray Pearson; Rolf A Brekken; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-31       Impact factor: 11.205

Review 8.  Between candidate genes and whole genomes: time for alternative approaches in blood pressure genetics.

Authors:  Jacob Basson; Jeannette Simino; D C Rao
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

9.  Crystal structure of domain-swapped STE20 OSR1 kinase domain.

Authors:  Seung-Jae Lee; Melanie H Cobb; Elizabeth J Goldsmith
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

10.  WNK1 protein kinase regulates embryonic cardiovascular development through the OSR1 signaling cascade.

Authors:  Jian Xie; Joonho Yoon; Sung-Sen Yang; Shih-Hua Lin; Chou-Long Huang
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.